Please provide your email address to receive an email when new articles are posted on . Irinotecan liposome injection combined with 5-FU/leucovorin and oxaliplatin prolonged OS compared with ...
Capstone Announces FDA Approval and EU Authorization of Doxorubicin Hydrochloride Liposome Injection
ROSEMONT, Ill., Dec. 14, 2022 /PRNewswire/ -- Capstone Development Services Company LLC ("Capstone") announced today that it has received approval from the U.S. Food and Drug Administration (FDA), as ...
Please provide your email address to receive an email when new articles are posted on . An irinotecan liposome injection regimen improved OS compared with standard chemotherapy among untreated ...
PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) announced today that it has completed its acquisition of global oncology assets from Merrimack Pharmaceuticals, in Cambridge, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback